United States Swab and Viral Transport Medium Market Size

The United States Swab and Viral Transport Medium Market is expected to grow from USD 4.47 billion in 2025 to USD 5.51 billion by 2035, reflecting a 2.1% compound annual growth rate (CAGR). This expansion aligns with national priorities focused on public health preparedness and diagnostic efficiency.

The market’s growth is attributed to several factors, including advancements in healthcare infrastructure, increased focus on high-accuracy diagnostics, and a shift towards specialized viral transport formulations. The market showed a slight increase in growth rates, with a CAGR of 2.3% in the first half of 2023, compared to a decline to 2.1% in early 2024. These fluctuations indicate evolving testing volumes and research & development cycles within healthcare institutions.

Recent innovations include McKesson’s introduction of next-generation swabs and viral transport media (VTMs) aimed at improving sample stability and diagnostic compatibility. In addition, Thermo Fisher is expanding its distribution network to meet rising diagnostic demands, while BD is investing in new VTM formulations.

The market is characterized by a mix of multinational and regional players, focusing on eco-friendly product designs and efficient transport systems. Continuous investment in research and development further supports the industry’s growth trajectory.

• Why it matters: The growth of this market highlights opportunities for businesses involved in diagnostics and public health, ensuring alignment with advancing healthcare technologies and demand.
• The latest: Innovations from major players continue to shape the landscape, enhancing the market’s capacity to meet emerging healthcare challenges.